Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis

• 1. 具有人类主要组织相容性复合物(MHC)表型的转基因小鼠、其实验性使用及用途 [P] . 中国专利： CN102727875A . 2012-10-17
• 2. 具有人类主要组织相容性复合物(MHC)表型的转基因小鼠、其实验性使用及用途 [P] . 中国专利： CN1859843A . 2006-11-08
• 3. Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis [P] . 美国专利： US5618680A . 1997-04-08

  机译： 对主要组织相容性复合物I类抗原具有特异性的配体在诊断子宫内膜异位症中的用途

• 4. Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis [P] . AU4295696A . 1996-07-19

  机译： 对主要组织相容性复合体I类抗原具有特异性的配体在诊断子宫内膜异位症中的用途

• 5. USE OF LIGANDS SPECIFIC TO MAJOR HISTOCOMPATIBILITY COMPLEX-CLASS I ANTIGENS FOR DIAGNOSING ENDOMETRIOSIS [P] . 世界知识产权组织专利： WO9620404A1 . 1996-07-04

  机译： 主要组织相容性复杂的I类特异性抗原在诊断子宫内膜异位症中的使用

• 1. Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan [J] . Yasuhide Kitagawa, Kazuaki Machioka, Hiroshi Yaegashi, 亚洲男性学杂志（英文版） . 2014,第006期
• 2. Self assembled monolayers versus iron oxide nanoparticles modified surfaces: Two functionalization strategies for femtomolar detection of prostate specific antigen: Comparative study between two electrochemical biosensors for femtomolar detection of prostate specific antigen [C] . Nesrine Blel, Nourdin Yaakoubi, Asma Omezzine, IEEE Sensors . 2016
• 3. Intercellular and intracellular events following the major histocompatibility complex-unrestricted T cell receptor recognition of a tumor-specific peptide epitope on the epithelial antigen MUC-1 [D] . Blander, Julie Margarian. 1997
• 4. CD40 Ligand-activated antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides [O] . Tahamtan Ahmadi, Amanda Flies, Yvonne Efebera, 2008
• 5. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides [O] . Ahmadi, Tahamtan, Flies, Amanda, Efebera, Yvonne, 2008
• 6. HLA(Human Leukocyte Antigen): The Major Histocompatibility Complex. Immunogenetics of HLA Antigens [R] . Johnson, A. H., Hartzman, R. J., Robinson, M. A. 1984

• 1. Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes [J] . Xian-Hui He ,Li-Hui Xu ,Yi Liu . 世界胃肠病学杂志：英文版 . 2005,第27期
• 2. Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients [J] . Gede Wirya Kusuma Duarsa ,Yudit Anastasia Sari ,Anak Agung Gde Oka . 亚洲泌尿外科杂志(英文) . 2021,第3期
• 3. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers [J] . Akiko Shida ,Takashi Fukuyama ,Nobue Futawatari . 世界胃肠病学杂志：英文版 . 2020,第4期
• 4. Peripheral tolerance of antigen-specific Th cells induced with polyethylene glycol-conjugate of protein antigen [J] . Masaomi Obata ,Takuma Fujii ,Mareki Ohtsuji . 免疫学期刊（英文） . 2013,第2期
• 5. 欧亚猞猁主要组织相容性复合物遗传多样性研究 [C] . 汪小方 ,韦鹍 ,张志和 . 野生动物生态与资源保护第五届全国学术研讨会 . 2009
• 6. 通过将猪主要组织相容性复合物SLA-1替换成人主要组织相容性复合物HLA-A建立用于异种移植的猪细胞系的研究 [A] . 曾晔临 . 2015